Ginkgo Bioworks Holdings Inc
NYSE:DNA

Watchlist Manager
Ginkgo Bioworks Holdings Inc Logo
Ginkgo Bioworks Holdings Inc
NYSE:DNA
Watchlist
Price: 9.03 USD -3.01% Market Closed
Market Cap: $520m

Operating Margin

-188%
Current
Improving
by 74.8%
vs 3-y average of -262.8%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-188%
=
Operating Income
$-339.5m
/
Revenue
$180.6m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-188%
=
Operating Income
$-339.5m
/
Revenue
$180.6m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Ginkgo Bioworks Holdings Inc
NYSE:DNA
513.2m USD
Loading...
US
Sherwin-Williams Co
NYSE:SHW
87.8B USD
Loading...
US
Ecolab Inc
NYSE:ECL
79.8B USD
Loading...
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
9.6T JPY
Loading...
CN
Wanhua Chemical Group Co Ltd
SSE:600309
275B CNY
Loading...
CH
Givaudan SA
SIX:GIVN
27.5B CHF
Loading...
DK
Novozymes A/S
CSE:NZYM B
165.6B DKK
Loading...
US
PPG Industries Inc
NYSE:PPG
25.8B USD
Loading...
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.3T INR
Loading...
CH
Sika AG
F:SIKA
19.9B EUR
Loading...
CH
DSM-Firmenich AG
AEX:DSFIR
17.5B EUR
Loading...

Market Distribution

Lower than 88% of companies in the United States of America
Percentile
12th
Based on 14 112 companies
12th percentile
-188%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Ginkgo Bioworks Holdings Inc
Glance View

Ginkgo Bioworks Holdings Inc. is at the forefront of the biotechnology revolution, pioneering the field of synthetic biology with a mission to harness the power of organisms to enable sustainable and innovative solutions across multiple industries. Founded in 2008, the company has developed a platform that leverages advanced genetic engineering techniques to design and program living cells, allowing them to produce everything from pharmaceuticals to sustainable materials. This unique approach not only simplifies and accelerates the product development process but also opens up a vast array of market opportunities, positioning Ginkgo as a key player in the bioeconomy. Their partnerships with established firms in sectors like agriculture, food, and pharmaceuticals underscore Ginkgo's capability to transform the way production is approached in these industries. As an investor, Ginkgo Bioworks represents a compelling opportunity, given its robust platform and growing clientele. The company's innovative use of genetic code to solve complex challenges is revolutionizing traditional manufacturing methods, aiming to reduce environmental impact while enhancing efficiency. Ginkgo's commitment to sustainability is reflected in its diverse product applications and collaborations with high-profile partners, which collectively enhance its revenue potential and market reach. With a strong focus on scalability and a seasoned leadership team, Ginkgo is well positioned to capitalize on the expanding demand for biotechnological solutions. This narrative not only highlights the company's technological prowess but also its strategic vision for a sustainable future, making it an attractive investment for those looking to align with forward-thinking, economically sound ventures.

DNA Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-188%
=
Operating Income
$-339.5m
/
Revenue
$180.6m
What is Ginkgo Bioworks Holdings Inc's current Operating Margin?

The current Operating Margin for Ginkgo Bioworks Holdings Inc is -188%, which is above its 3-year median of -262.8%.

How has Operating Margin changed over time?

Over the last 3 years, Ginkgo Bioworks Holdings Inc’s Operating Margin has increased from -690% to -188%. During this period, it reached a low of -690% on Sep 30, 2022 and a high of -131.8% on Jun 30, 2025.

Back to Top